Molecular BCR::ABL1 quantification and ABL1 mutation detection as essential tools for the clinical management of chronic myeloid leukemia patients: results from a Brazilian single-center study

Marin, Anelis Maria; Wosniaki, Denise Kusma; Sanchuki, Heloisa Bruna Soligo; Munhoz, Eduardo Cilião; Nardin, Jeanine Marie; Soares, Gabriela Silva; Espinace, Dhienifer Caroline; Farias, João Samuel de Holanda; Veroneze, Bruna; Becker, Luiz Felipe; Costa, Guilherme Lima; Beltrame, Olair Carlos; Oliveira, Jaqueline Carvalho de; Cambri, Geison; Zanette, Dalila Luciola; Aoki, Mateus Nóbrega.
Artículo en Portugués | ARCA | ID: arc-59733

Documentos relacionados

  1. Optimizing patient selection for treatment-free remission.
  2. Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects.
  3. One-month qRT-PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission.
  4. Medical Devices; Immunology and Microbiology Devices; Classification of the BCR­ABL Quantitation Test. Final order.
  5. BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
  6. Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.
  7. Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial.
  8. Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory.
  9. Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia.
  10. Asymptomatic chronic-phase chronic myeloid leukemia BCR-ABL. (+) without splenomegaly: A case report.